Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
3. Cardiac Dimensions adds $15m for Carillon mitral valve implant
Cardiac Dimensions today said it raised another $15.2 million for its Carillon mitral valve implant, taking the total of its most recent funding round to $43 million.
The round included new investors Life Sciences Partners and Aperture Venture Partners, plus existing backers Lumira Capital, M.H. Carnegie & Co., and Arboretum Ventures. Read more
2. Inogen delays earnings on ‘potential accounting matters’
Inogen said it discovered “certain potential accounting matters” that prompted it to delay the release of its 4th-quarter and 2014 results pending further investigation into the matter.
Goleta, Calif.-based Inogen said its board’s audit committee launched an internal probe into the unspecified issues, but hasn’t come to any conclusions yet. Inogen said it still expects to meet its forecast for 2015. Read more
1. Appeals court upholds AngioDynamics injunction, $160m penalty against Biolitec
A federal appeals court yesterday upheld a pair of legal wins for AngioDynamics in its long-running dispute with former partner Biolitec, but remanded the case to a lower court to adjust contempt-of-court fines for Biolitec that have topped the $160 million mark.
A Massachusetts judge last year trebled a $23 million jury award to AngioDynamics in a harshly-worded decision finding that Biolitec deliberately effected a so-called “downstream merger” to move its incorporation to Austria to escape jurisdiction in U.S. courts. Read more
